Cocrystal Pharma, Inc. (COCP)
USD 2.11
(6.57%)
USD 2.11
(6.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.66 Million | -21.43 Million | -12.71 Million | -9.83 Million | -1.56 Million | -8.29 Million |
| Net Income | -17.98 Million | -38.83 Million | -14.18 Million | -9.64 Million | -48.16 Million | -49.04 Million |
| Depreciation & Amortization | -1.38 Million | 388 Thousand | 190 Thousand | 157 Thousand | 98 Thousand | 50 Thousand |
| Deferred income taxes | 3.84 Million | - | -49 Thousand | 54 Thousand | 45.84 Million | -13.58 Million |
| Stock-based compensation | 801 Thousand | 855 Thousand | 724 Thousand | 662 Thousand | 351 Thousand | 562 Thousand |
| Change in working capital | 2.34 Million | -2.71 Million | 796 Thousand | -878 Thousand | 443 Thousand | 117 Thousand |
| Other non-cash items | -2.28 Million | 18.87 Million | -195 Thousand | -177 Thousand | -133 Thousand | 53.61 Million |
| Investing Cash Flow | -118 Thousand | -74 Thousand | -52 Thousand | -240 Thousand | -145 Thousand | 1.37 Million |
| Investments in PPE | -118 Thousand | -74 Thousand | -52 Thousand | -240 Thousand | -145 Thousand | -28 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 1.4 Million |
| Financing Cash Flow | 3993.00 | -27 Thousand | 38.46 Million | 35.66 Million | 6.42 Million | 8.89 Million |
| Debt repayment | -7.00 | -27 Thousand | -39 Thousand | -121 Thousand | -214 Thousand | -19 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4 Million | - | 38.5 Million | 35.78 Million | 6.63 Million | 7.68 Million |
| Other Financing Activities | 4000.00 | -27.00 | 38.5 Thousand | 35.66 Thousand | 6424.00 | 1.22 Million |
| Accounts receivables | -174 Thousand | -716 Thousand | 556 Thousand | 88 Thousand | -644 Thousand | - |
| Accounts payables | 2.04 Million | -321 Thousand | 217 Thousand | -919 Thousand | 919 Thousand | - |
| Inventory | - | 716 Thousand | -217 Thousand | 919 Thousand | -919 Thousand | - |
| Other working capital | 470 Thousand | -2.39 Million | 240 Thousand | -966 Thousand | 1.08 Million | 117 Thousand |
| Cash at beginning of period | 37.21 Million | 58.75 Million | 33.06 Million | 7.46 Million | 2.75 Million | 777 Thousand |
| Cash at end of period | 26.42 Million | 37.21 Million | 58.75 Million | 33.06 Million | 7.46 Million | 2.75 Million |
| Capital Expenditure | -118 Thousand | -74 Thousand | -52 Thousand | -240 Thousand | -145 Thousand | -28 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -10.79 Million | -21.53 Million | 25.69 Million | 25.59 Million | 4.71 Million | 1.97 Million |
| Free Cash Flow | -14.78 Million | -21.5 Million | -12.77 Million | -10.07 Million | -1.7 Million | -8.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.34 Million | -3.95 Million | -4.46 Million | -17.98 Million | -4.16 Million | -4.16 Million |
| Depreciation & Amortization | 33 Thousand | 35 Thousand | -1.7 Million | -1.38 Million | 108 Thousand | 101 Thousand |
| Deferred income taxes | - | - | 2.38 Million | 3.84 Million | - | - |
| Stock-based compensation | 148 Thousand | 157 Thousand | 158 Thousand | 801 Thousand | 173 Thousand | 179 Thousand |
| Change in working capital | 1.45 Million | -739 Thousand | 893.36 Thousand | 2.34 Million | 1.26 Million | -1.6 Million |
| Other non-cash items | 84.05 Thousand | 1.22 Million | -134.32 Thousand | -2.28 Million | -57 Thousand | -59 Thousand |
| Investing Cash Flow | 59.17 | -8000.00 | -57 Thousand | -118 Thousand | -1543.65 | -14 Thousand |
| Investments in PPE | 59.17 | -8000.00 | -57 Thousand | -118 Thousand | -1543.65 | -14 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -174.36 Thousand | 3993.00 | 104.47 Thousand | 4000.00 |
| Debt repayment | - | - | -305.68 | -7.00 | -183.14 | -191.94 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -174.67 Thousand | 4 Million | 104.65 Thousand | 4.1 Million |
| Other Financing Activities | - | - | - | 4000.00 | - | 4000.00 |
| Accounts receivables | -72.61 Thousand | -113 Thousand | -350.62 Thousand | -174 Thousand | 679.35 Thousand | -264.46 Thousand |
| Accounts payables | 268.57 Thousand | -883 Thousand | 1.19 Million | 2.04 Million | 417.27 Thousand | -1.5 Million |
| Inventory | - | - | 1.00 | - | -71.09 Thousand | -3756.00 |
| Other working capital | 1.26 Million | 257 Thousand | 52.17 Thousand | 470 Thousand | 234.46 Thousand | 169.01 Thousand |
| Cash at beginning of period | 21.91 Million | 26.42 Million | 29.81 Million | 37.21 Million | 32.49 Million | 34.05 Million |
| Cash at end of period | 18.21 Million | 21.91 Million | 26.42 Million | 26.42 Million | 29.81 Million | 32.49 Million |
| Capital Expenditure | 59.17 | -8000.00 | -57 Thousand | -118 Thousand | -1543.65 | -14 Thousand |
| Effect of forex changes on cash | - | - | -289.85 Thousand | - | -102.92 Thousand | - |
| Net cash flow / Change in cash | -3.69 Million | -4.51 Million | -3.38 Million | -10.79 Million | -2.68 Million | -1.56 Million |
| Free Cash Flow | -3.63 Million | -4.51 Million | -2.92 Million | -14.78 Million | -2.68 Million | -5.56 Million |
MTAV
LPPS
5703
001440
688768
2156